Skip to main content
logo
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.6862
-0.0038 (-0.55%)
Aug 18, 2026, 11:46 AM EDT - Market open

Aprea Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
96181818-
Market Cap Growth
-12.24%-66.64%1.81%0.11%--
Enterprise Value
-33-7-7-6-12-
Last Close Price
0.690.853.294.706.62-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1675.5820.8811.9030.11--
PB Ratio
0.220.450.870.960.65-
P/TBV Ratio
0.230.480.931.040.68-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-----0.00
Net Debt / Equity Ratio
-1.05-1.11-1.11-1.18-1.07-1.07
Net Debt / EBITDA Ratio
3.121.111.601.400.771.41
Net Debt / FCF Ratio
3.381.131.681.761.151.40
Asset Turnover
00.010.060.02--
Quick Ratio
13.335.286.804.938.997.25
Current Ratio
13.555.637.025.149.427.73
Return on Equity (ROE)
-46.15%-74.58%-66.66%-63.19%-294.69%-
Return on Assets (ROA)
-27.73%-41.45%-38.39%-36.62%-53.71%-
Return on Capital Employed (ROCE)
-33.70%-100.50%-69.50%-84.70%-138.60%-75.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-141.66%-211.20%-72.47%-81.35%-642.23%-
FCF Yield
-140.23%-216.14%-75.90%-69.87%-142.58%-
Buyback Yield / Dilution
-243.85%-18.67%-52.31%-118.31%-55.69%-0.72%
SEC Filings: 10-K · 10-Q